![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, December 13, 2017 8:38:40 AM
-
Doral, FL, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK:ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical, medical device, research and development, signs distribution agreement with Mr. Checkout, beginning in 2018, and coinciding with the company’s new CBD product revamp.
ETST looks to start the year strong, adding it’s first major distributor to the already strong and growing team of representatives across the U.S. The company currently has 10 active representatives opening and managing accounts across the states, one of which recently joined in December and immediately began bringing in a good number of chain stores. The representatives have been very successful with health food stores and clinics. ETST has signed a distribution agreement with Mr. Checkout to open and manage major retailers and stores within the U.S., which substantially expands the company’s reach.
Mr. Checkout, as featured on ABC’s Shark Tank, is a national group of independent distributors, full-line grocery distributes, and convenience stores. Mr. Checkout represents products in over 60 major retailers throughout the U.S. and approximately 55,000 stores. A few of Mr. Checkout’s accounts are Walgreens, CVS, Walmart, Wholefoods Market, and Target, just to name a few.
Gabriel Aviles, ETST’s Chief Sales Officer & Director states, “I feel that we have finally put together a solid productive team of representatives that we needed to continue expanding our presence in health shops and clinics. Now, with Mr. Checkout, we will be able to take our presence and sales to the next level, entering larger retailers and many stores. 2018 looks to be starting off very strong with our new product revamp, marketing and education strategy, and sales channel.”
ETST’s President, Director, & COO concludes with, “Gabriel has done a remarkable job building our sales team and expanding our presence across the U.S. I have no doubt that 2018 is going to be a solid year of growth for us, with all we have initiating as early as January alone, with our CBD products. Our MSN-2 medical device globalization strategy is still on track, and we are currently in talks with institutional investors thanks to our planned up-listing in Q1 2018. I plan on sharing further updates as they progress on the MSN-Medical device, IP patents, CBD based pharmaceutical generic drugs, and our new CBD formula opioid clinical trials as they progress.”
Recent ETST News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 07:35:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2024 10:10:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 12:28:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 03:10:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 06:23:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 08:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 12:52:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:20:11 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/27/2024 01:30:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:05:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 02:05:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 05:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:59:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2023 11:01:45 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 12:50:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/14/2023 11:08:45 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 04:51:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 11:16:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 01:01:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 03:41:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/28/2023 01:10:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/27/2023 08:53:38 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM